Spinal Surgery, Cement Systems - Orthoworld

More documents

Recommendations

Info

EXECUTIVE INTERVIEW Glen Kashuba Senior Vice President of Biomet, Inc., President of Biomet Spine • Biomet Trauma Glen Kashuba is the Senior Vice President of Biomet, Inc. and President of Biomet Spine • Biomet Trauma. With nearly 25 years of experience in the medical industry, he has been at the helm of Biomet Spine • Biomet Trauma since April 2007. Prior to Biomet, Mr. Kashuba had worked for Johnson & Johnson for nine years. He served as Worldwide President of Cordis Endovascular, Worldwide President of Codman Neuro Science and U.S. President of DePuy AcroMed, now known as DePuy Spine. Mr. Kashuba also held several key management positions during his eleven years with Howmedica/Pfizer. ORTHOPAEDIC PRODUCT NEWS (OPN): You took the helm of Biomet Spine • Biomet Trauma about two years ago. How would you summarize those first two years? Exhibit 1: Biomet’s Pathway To Growth Glen Kashuba (GK): It is fair to say we had some work to do. The business had stagnated and the organizational environment was chaotic. We needed to focus and rebuild the foundation. I viewed this as the first step on a “Pathway To Growth.” Fortunately, despite the bedlam, many good people stayed with the organization. We also hired senior leadership, those who have worked in the spine and trauma businesses for many years. We concentrated on the most critical fundamentals: supply chain management, sales force recruitment and launching new products. By the end of the first year of the rebuilding process (mid- 2008), we had repaired the business and were in a position to begin the second phase of the “Pathway To Growth,” a re-launch of the company. We focused on building our R&D portfolio and reconnecting with the surgeon community. We increased the size and breadth of our R&D department. We began several important new projects with surgeon thought leaders. We actively pursued internal R&D feasibility investigations with major academic institutions. Our L&A activities significantly increased. In addition, we committed to support our product portfolio by increasing our surgeon education presence. By the end of the re-launch phase, in mid-2009, we had stabilized the trauma business and had achieved strong growth in spine. We feel the re-launch of this company has succeeded. Now we will move into a new phase, one of accelerated growth for our spine and trauma businesses, as well as our bracing and bone growth stimulation lines. (See Exhibit 1.) continued on page 19 18 ORTHOPAEDIC PRODUCT NEWS • September/October 2009
EXECUTIVE INTERVIEW continued from page 18 OPN: During the accelerated growth phase, what do you expect spine surgeons will notice about the Biomet Spine product portfolio? GK: Spine surgeons will see the impact of our recently released products. We have rounded out our very successful Polaris 5.5 and 6.35 Thoracolumbar Systems with the introduction of a new Polaris Deformity System. During July and August we obtained FDA clearance for all of the options required to perform complex thoracolumbar surgery. In addition to the new Polaris Deformity System, we now offer The Trivium Derotation System that incorporates Enbloc vertebral body derotation via an innovative, simple correction technique. The system utilizes the strength of pedicle screw fixation and enables surgeons to correct most spinal deformities in three dimensions. Surgeons have responded very well to this system. We have increased our inventory so that now many more surgeons will have the opportunity to use our Trivium and Polaris Systems. (See Exhibit 2.) Exhibit 2: Polaris and Trivium Systems OPN: During the accelerated growth phase, what do you expect trauma surgeons will notice about the Biomet Trauma portfolio? GK: Surgeons will notice a significant number of new products. Each one will have a substantial number of sets to support surgeons around the country. Significant inventory is one of the biggest changes in our trauma business. We understand that a great product released with a small number of sets cannot make an impact. Our new product designs include the Phoenix Ankle Arthrodesis Nail System, our latest addition to Biomet Trauma’s family of intramedullary nailing systems (See Exhibit 3.); the Forerunner Plating System, a comprehensive plating system designed for fixation of bony pathology for the foot and ankle; and the Biomet® Vision FootRing System, a lightweight radiolucent component-based system capable of a multitude of customizable constructs ranging from simple fractures to complex reconstruction. We have received a great response from surgeons who have used these technologies. Our commitment to additional inventory will make our products increasingly available, allowing us to win more surgeons to our product lines. Exhibit 3: Phoenix Ankle Arthrodesis Nail System OPN: During the accelerated growth phase, what do you expect physicians will notice about the Biomet Bracing portfolio? We will continue to build on the success of our C-Tek® MaxAn Anterior Cervical Plate System. The system offers an innovative one-level plate technique that provides a direct relationship between the bone graft/spacer size and the position of the plate holes. The implant can obtain a cephalad-caudal sweep of 60° which allows for screw placement to be close to the endplates. We also have had a great response to the Solitaire System, an ALIF spacer designed to provide immediate mechanical fixation to adjacent vertebral bodies with no anterior column profile. A shallow screw angle helps provide strong fixation by maximizing thread contact with cortical bone. The subsidence-resistant open design helps preserve the endplate. The large, medial cavity facilitates the fusion process, and a variety of footprints and heights suit varying anatomies. We will continue to promote this product to surgeons performing Anterior Lumbar Interbody Fusion (ALIF) procedures. GK: As a result of improved process flows, Biomet Bracing customers can expect faster turnaround for their customized braces. Biomet Bracing offers a number of new customized braces and off-the-shelf products including the Performance® Knee Brace line, Aspen® Spine Braces and Cold Therapy solutions. We are also excited about our new Biomet Link System (See Exhibit 4.), a DME Billing System designed to minimize the risk and hassle of supplies management, billing and claims administration. By automating the entire process, Biomet Link removes the complications of ordering product, managing inventory, dispensing product, coding and charging correctly and creating, submitting and reconciling claims. We believe all of these products will catch the attention of current customers and those who have not taken a look at us in some time. continued on page 20 September/October 2009 • ORTHOPAEDIC PRODUCT NEWS 19
Page 1: September/October 2009
Page 4: FROM THE EDITOR Dear Doctor, The pa
Page 7 and 8: EDITORIAL continued from page 6 Sec
Page 10 and 11: SURGEON AS ENTREPRENEUR continued f
Page 12 and 13: SURGEON AS ENTREPRENEUR A Roadmap t
Page 14: SURGEON AS ENTREPRENEUR continued f
Page 20 and 21: EXECUTIVE INTERVIEW continued from
Page 22 and 23: PRODUCT NEWS AND LAUNCHES Locking P
Page 24 and 25: ARTICLE Physician Dispensing: A Cos
Page 26 and 27: PRACTICE MANAGEMENT SOLUTIONS The B
Page 28: EDITORIAL Controlling Device Costs:
Page 31 and 32: POSITION PAPER continued from page
Page 33 and 34: ORTHOINVESTOR UPDATE Ticker Track (
Page 36: FUTURETECH A Solution for Undercodi
Page 39 and 40: FUTURETECH continued from page 38 E
Page 42 and 43: ARTICLE continued from page 40 The
Page 44 and 45: VIEWS ON THE NEWS In this feature,
Page 46 and 47: PRODUCT FEATURES Anspach Minimal Ac
Page 48 and 49: CALENDAR OF EVENTS September 2009 S
Page 50 and 51: THE TOP LINE Employment Agreements:
Page 52: FISCAL FITNESS UPDATE Update: Infor
Page 55 and 56: GIVING BACK We were able to do so m
Page 58: GIVING BACK continued from page 56

Spinal Surgery, Cement Systems - Orthoworld

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?